Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
“You must be closed up because you HIV people like making babies, and it just annoys us.”
In theory, starting antiretrovirals quiets the immune system, leading more immune cells to become part of the inactive reservoir.
Conducted in South Africa, it’s one of three major late-stage trials.
A South African study found that treating the virus within 48 hours or waiting up to two weeks led to comparable viral suppression rates.
A pair of studies focused on KwaZulu-Natal, South Africa.
Only HIV vax to show any efficacy prompted strong immune response in new study
A long-term study found that kidney transplants between people with HIV have high success rates.
This finding suggests that the HIV-preventing vaginal ring that awaits regulatory approval may achieve widespread use.
People with HIV make their own artistic statement in the photo-storytelling project “Through Positive Eyes.”
The rollout of antiretroviral treatment in this hard-hit region has apparently not lowered this group’s risk of acquiring HIV.
A long-term study also found that superinfection—acquiring a second strain of HIV—was not a risk for the transplantees.
Peace Corps Response volunteer Brian Sway’s work just earned him a prestigious award.
The vaccine in the APPROACH study, which led to the Imbokodo and forthcoming Mosaico trails, prompted a robust immune response.
Receiving viral load results within hours as opposed to weeks was linked to higher rates of HIV suppression and retention in medical care.
The largest-ever HIV prevention study found that door-to-door HIV testing, with linkage to treatment, lowered infection rates.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.